INDIANAPOLIS, Sept. 28, 2015 /PRNewswire/ -- The American Institute of Toxicology, Inc. (AIT), also known as AIT Laboratories, is marking two and a half decades of excellence in toxicology. On Thursday, October 1, at 4 p.m., AIT will honor company founder Dr. Michael A. Evans and long-term employees and celebrate the company's 25th anniversary at an event to be held in AIT's 7820 Innovation Boulevard office building in Indianapolis.
"While AIT is celebrating the past 25 years, we are also looking ahead to the future, which requires innovation," said AIT President and CEO, R. Matthew Neff. "We have a growing prescription drug misuse problem in this country. Monitoring is key to solving the problem. GuideMed®, a prescription narcotics monitoring program developed and patented by AIT, combined with toxicology testing, is now more important than ever."
AIT has seen periods of significant growth since Evans founded the company in 1990 with five employees and a goal of providing superior analytical testing and research to professionals in the healthcare industry. The company's forensic toxicology testing business recently celebrated its most successful month ever and continues to see significant growth.
"While newcomers have fallen by the wayside, AIT's 25 years of ethical behavior has kept the company healthy," said Evans.
In 2005, the company began providing toxicology testing to healthcare providers for the purposes of monitoring patients prescribed narcotics for treatment of chronic pain. In 2014, AIT launched GuideMed, a service that helps healthcare organizations develop and implement standardized prescription narcotics monitoring programs. GuideMed helps ensure patients are treated safely and fairly while helping organizations prevent prescription narcotics misuse, meet state opioid prescribing requirements and reduce risk.
GuideMed nurses meet with patients and complete tasks associated with the organization's patient monitoring program. Because GuideMed absorbs much of the workload, the organization's healthcare providers have more time available to focus on treating their patients.
"We make sure each patient is monitored according to the health system's protocols," said Gina Cooper, R.N., B.S.N., Manager of GuideMed® Clinical Support. "We help health systems meet the state's requirements more efficiently. Providers really benefit from our support and the outcomes we've achieved show it."
SOURCE The American Institute of Toxicology, Inc.